It was specifically FDA-approved for chronic weight management in adults with obesity or those who are overweight with at least one weight-related condition, such as high blood pressure or type 2 diabetes
In tirzepatide trials, reductions were often larger, with some analyses showing average decreases of 25 to 30% or more at higher doses
Want to go deeper on GLP-1 medications and heart health
Compatible with a wide range of research peptides
196,197 Such studies have identified a low-frequency variant of CD300LG that is associated with fasting high-density lipoprotein cholesterol (HDL-C), 198 and a TBC1D4 variant that together are connected to higher fasting glucose levels and reduced insulin sensitivity
Full breakdown of the pathway, the regulatory citations, and the documented medical-need criteria RxPepsDirect providers use is on our compounded tirzepatide legality page